Skip to main content

Table 2 Univariate and multivariate analysis for a’ velocity

From: Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy

 

a’

LA dysfunction (a’ < 6 cm/s)

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

(r)

(p)

(β)

(p)

OR (95% CI)

p

OR (95% CI)

p

Age, per year

0.102

0.166

  

0.98 (0.95–1.01)

0.098

  

Dynamic obstruction

−0.069

0.348

  

3.68 (1.60–8.45)

0.002

  

ApHCM

0.182

0.013

0.057

0.341

0.38 (0.16–0.90)

0.029

1.34 (0.39–4.57)

0.638

LVEF-by echo, per %

0.030

0.683

  

0.93 (0.88–0.99)

0.015

  

E, per cm/s

−0.260

< 0.001

  

26.39 (3.40–204.94)

0.002

  

A, per cm/s

0.291

< 0.001

  

0.06 (0.006–0.49)

0.009

  

e’, per 100 cm/s

0.232

0.001

  

0.74 (0.57–0.97)

0.030

  

E/e’

0.411

< 0.001

−0.089

0.190

1.17 (1.08–1.25)

< 0.001

1.07 (0.97–1.17)

0.182

s’, per 100 cm/s

0.592

< 0.001

0.484

< 0.001

0.47 (0.34–0.65)

< 0.001

0.52 (0.34–0.78)

0.001

LA volume index, per mL/m2

−0.418

< 0.001

− 0.200

0.002

1.05 (1.03–1.07)

< 0.001

1.04 (1.01–1.07)

0.004

Presence of sarcomere mutations

0.211

0.004

−0.138

0.017

4.76 (2.05–11.02)

< 0.001

5.33 (1.71–16.61)

0.004

LV mass index by CMR (n = 135)

−0.214

0.021

  

1.02 (1.00–1.05)

0.046

  

Presence of LGE (n = 133)

−0.248

0.007

  

1.89 (0.49–7.21)

0.353

  

No of LGE segment (n = 133)

−0.334

< 0.001

  

1.26 (1.07–1.49)

0.006

  

%LGE mass (n = 133)

−0.132

0.156

  

1.03 (0.97–1.09)

0.312

  

LV myocardial GLS (n = 135)

−0.045

0.627

  

1.05 (0.93–1.18)

0.435

  

LA GLS (n = 135), per %

0.076

0.413

  

0.92 (0.85–0.99)

0.034

  

LA minimal volume (n = 135), per mL

−0.443

< 0.001

  

1.03 (1.02–1.05)

< 0.001

  

LA maximal volume (n = 135), per mL

−0.427

< 0.001

  

1.02 (1.01–1.04)

0.001

  

LA total emptying fraction (n = 135), per %

0.251

0.006

  

0.93 (0.89–0.97)

0.001

  

LA active emptying fraction (n = 119), per %

0.248

0.006

  

0.93 (0.88–0.97)

0.003

  

5-yr-SCD risk (n = 123)

−0.314

0.001

  

1.45 (1.06–1.99)

0.020

  

Presence of NSVT (n = 123)

−0.214

0.036

  

5.27 (1.58–17.66)

0.007

  
  1. Abbreviations are same as in Table 1